Big Oriental announced that the cumulative deviation value of the daily closing price increase reached 29.26% for three consecutive trading days on November 5, November 6, and November 9, 2026, constituting abnormal fluctuations in stock trading. After self-inspection and written inquiries to the controlling shareholders and actual controllers, as of the date of disclosure of the announcement, the company had no significant information that should have been disclosed but not disclosed, production and operation activities were normal, and there were no major changes in the main business. Revenue for the first three quarters of 2026 was 1,941 million yuan, down 26.61% year on year; net profit attributable to shareholders of listed companies was 8.4092 million yuan, down 84.89% year on year. As of November 6, 2026, the latest static price-earnings ratio for the “medical service” industry listed by the company was 35.29, and the latest static price-earnings ratio for the “health” industry was 37.77.

Big Oriental announced that the cumulative deviation value of the daily closing price increase reached 29.26% for three consecutive trading days on November 5, November 6, and November 9, 2026, constituting abnormal fluctuations in stock trading. After self-inspection and written inquiries to the controlling shareholders and actual controllers, as of the date of disclosure of the announcement, the company had no significant information that should have been disclosed but not disclosed, production and operation activities were normal, and there were no major changes in the main business. Revenue for the first three quarters of 2026 was 1,941 million yuan, down 26.61% year on year; net profit attributable to shareholders of listed companies was 8.4092 million yuan, down 84.89% year on year. As of November 6, 2026, the latest static price-earnings ratio for the “medical service” industry listed by the company was 35.29, and the latest static price-earnings ratio for the “health” industry was 37.77.